Split History
ETFs Holding AVXL »    AVXL Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Anavex Life Sciences is a clinical stage biopharmaceutical company engaged in the development of therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer's disease, other central nervous system diseases, pain and various types of cancer. Co.'s primary compounds ANAVEXTM 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome. Co.'s proprietary SIGMACEPTOR™ Discovery Platform produced small molecule drug candidates with certain modes of action, based on Co.'s understanding of sigma receptors. According to our AVXL split history records, Anavex Life Sciences has had 1 split.
AVXL split history picture
Anavex Life Sciences (AVXL) has 1 split in our AVXL split history database. The split for AVXL took place on October 28, 2015. This was a 1 for 4 reverse split, meaning for each 4 shares of AVXL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.

When a company such as Anavex Life Sciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the AVXL split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Anavex Life Sciences shares, starting with a $10,000 purchase of AVXL, presented on a split-history-adjusted basis factoring in the complete AVXL split history. AVXL split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/25/2007
End date: 01/23/2017
Start price/share: $12.40
End price/share: $4.20
Dividends collected/share: $0.00
Total return: -66.13%
Average Annual Total Return: -10.26%
Starting investment: $10,000.00
Ending investment: $3,386.35
Years: 10.00
Date Ratio
10/28/20151 for 4
AVXL is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AZN Split History
BAX Split History
BCR Split History
BDMS Split History
BDX Split History
BGMD Split History
BIO Split History
BIOC Split History
BIOD Split History
BIOL Split History

DryShips Inc. (DRYS)
WisdomTree SmallCap Earnings Fund (EES)
WisdomTree MidCap Earnings Fund (EZM)
RGC Resources, Inc. (RGCO)
Sunshine Heart, Inc. (SSH)
Neuralstem, Inc. (CUR)
Gevo, Inc. (GEVO)
Interpace Diagnostics Group, Inc. (IDXG)
EnteroMedics Inc. (ETRM)
First Foundation Inc. (FFWM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AVXL Insider Buying

AVXL Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.